RA PHARMACEUTICALS, INC. — Operating Income by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/6995f82d-00ef-4c26-a3d9-af3301de35ac/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2019 | $-107.0M | 2019-01-01 – 2019-12-31 | evidence 0001047469-20-001072 |
| FY 2018 | $-66.4M | 2018-01-01 – 2018-12-31 | evidence 0001047469-19-000968 |
| FY 2017 | $-55.0M | 2017-01-01 – 2017-12-31 | evidence 0001047469-18-001637 |
| FY 2016 | $-28.0M | 2016-01-01 – 2016-12-31 | evidence 0001047469-17-001292 |
| FY 2015 | $-13.4M | 2015-01-01 – 2015-12-31 | evidence 0001047469-17-001292 |
| FY 2014 | $-7.1M | 2014-01-01 – 2014-12-31 | evidence 0001047469-17-001292 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).